This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The Schepens Eye Research Institute, Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Keiko Mizumoto: Innovator in Retinal Stem Cell Research
Introduction
Keiko Mizumoto is a pioneering inventor based in Higashi, Japan. She has made significant contributions to the field of retinal stem cell research, focusing on innovative methods for isolation and transplantation. Her work aims to advance the understanding and treatment of retinal diseases.
Latest Patents
Mizumoto holds a patent for the "Isolation and transplantation of retinal stem cells." This invention relates to the isolation, in vitro propagation, and transplantation and integration of non-pigmented retinal stem cells derived from the neuroretina of the eye, both ex vivo and in vivo. This groundbreaking work has the potential to transform therapeutic approaches for retinal conditions.
Career Highlights
Keiko Mizumoto is affiliated with the Schepens Eye Research Institute, Inc., where she collaborates with leading experts in the field. Her research has garnered attention for its innovative approach to stem cell therapy and its implications for vision restoration.
Collaborations
Mizumoto has worked alongside notable colleagues, including Michael J. Young and Henry Klassen. These collaborations have enriched her research and expanded the impact of her findings in the scientific community.
Conclusion
Keiko Mizumoto's contributions to retinal stem cell research exemplify the spirit of innovation in the medical field. Her work not only advances scientific knowledge but also holds promise for improving the lives of individuals with retinal diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile